2005
DOI: 10.1097/00000542-200505000-00016
|View full text |Cite
|
Sign up to set email alerts
|

Clinically Relevant Concentrations of Propofol but Not Midazolam Alter In Vitro  Dendritic Development of Isolated γ-Aminobutyric Acid-positive Interneurons

Abstract: Short-term exposure of immature developing GABAergic neurons to clinically relevant concentrations of propofol can induce long-term changes in dendritic arbor development. These results suggest that propofol anesthesia during central nervous system development could interfere with the molecular mechanisms driving the differentiation of GABAergic neurons and thus could potentially lead to impairment of neural networks.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
74
0
1

Year Published

2012
2012
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 107 publications
(78 citation statements)
references
References 0 publications
3
74
0
1
Order By: Relevance
“…As previously reported, steady-state anesthesia levels of propofol are 2-5 mg/mL in humans and 20-60 mg/mL in animals (Feiner et al, 2005). Our results are consistent with previous reports showing that clinically relevant concentrations of propofol result in cell death of GABAergic neurocytes in neonates (Vutskits et al, 2005). In contrast, aggregating fetal (16 days of gestation) rat brain glial cells have been shown to develop resistance to propofol even at doses of 10 mg/mL (Honegger and Matthieu, 1996), although the reasons for the discrepancy observed still remain unclear.…”
Section: Figsupporting
confidence: 93%
“…As previously reported, steady-state anesthesia levels of propofol are 2-5 mg/mL in humans and 20-60 mg/mL in animals (Feiner et al, 2005). Our results are consistent with previous reports showing that clinically relevant concentrations of propofol result in cell death of GABAergic neurocytes in neonates (Vutskits et al, 2005). In contrast, aggregating fetal (16 days of gestation) rat brain glial cells have been shown to develop resistance to propofol even at doses of 10 mg/mL (Honegger and Matthieu, 1996), although the reasons for the discrepancy observed still remain unclear.…”
Section: Figsupporting
confidence: 93%
“…Neuronal deficit in pathological conditions has been reported to induce disturbance of synapse formation (Nikzad et al, 2007), so the decrease of synaptic density induced by multiple propofol exposures may attribute to neuronal deficit to some extent. Additionally, propofol with clinically relevant concentrations can cause neurite retraction (Turina et al, 2008), growth cone collapse (Al-Jahdari et al, 2006) and a persistent decrease in dendritic growth (Vutskits et al, 2005), which suggests decreased synaptic density induced by propofol may result from its straight inhibition on synapse formation as well. The present study, for the first time, demonstrates that repeated but not single exposure to propofol during critical periods of synaptogenesis induces persistent synaptic loss both in hippocampus and the PrL, which suggests that the effects of propofol-induced inhibition of synapse formation are exposure times dependent.…”
Section: Discussionmentioning
confidence: 99%
“…Such neurotoxicity has now been demonstrated not only for isoflurane [1] but also for ketamine [2] , midazolam [2] , diazepam, pentobarbital [3] , thiopental [4] , N 2 O [5] and propofol [4,[6][7][8] . Pregnant women, newborns, and infants are often exposed to anesthetic agents during childbirth or for surgical procedures.…”
Section: Introductionmentioning
confidence: 99%